Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

There have been new developments in treatments for chronic spontaneous urticaria, with dupilumab, remibrutinib, and barzolvolimab showing complete response in patients, particularly among those who ...

Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

Inebilizumab, a first-in-class CD19+ B-cell–targeting agent, is safe and effective for up to 1 year in patients with ...

Moreover, the panelists emphasized that real-world evidence goes beyond clinical trial data. It involves continuous patient monitoring, proactive adverse effect management, and adapting protocols ...

DURING secondary response, elicited in sensitized rabbits ... simultaneously with the formation of antibodies 1. The cellular reaction was localized almost exclusively to the red pulp, especially ...

In Brazil, a group of researchers from the Federal University of São Paulo (UNIFESP) and the Butantan Institute have ...

World Health Organization members are finalizing plans for nations to share life-saving technology with developing countries ...

Diagnosis utilizes detailed medical history, clinical evaluation, skin testing, food-specific IgE antibodies, responses to elimination diet and oral food challenges. Endoscopic biopsies are ...

However, the formation of anti-drug antibodies (ADA) against a biological can result in reduced clinical response in some patients. Measurement of ADA in the presence of (high) drug levels is ...

The test doesn't detect the virus itself but instead detects antibodies—called immunoglobulin G (IgG)—produced by the immune system in response to the virus. A positive test result indicates that you ...